Home » Topics » BioWorld Science

BioWorld Science
RSS

Imfinzi approved in E.U. for locally advanced, unresectable NSCLC

Sep. 25, 2018

FDA lifts partial clinical hold on tazemetostat trials

Sep. 25, 2018

New PKU mouse model developed

Sep. 25, 2018

AnaptysBio reports promising topline proof-of-concept data on etokimab in severe eosinophilic asthma

Sep. 25, 2018

Ovid initiates phase II studies of OV-935 for rare epilepsies

Sep. 25, 2018

FDA lifts clinical hold for Sarepta's DMD micro-dystrophin gene therapy program

Sep. 25, 2018

PhaseBio reports promising phase I results with ticagrelor reversal agent PB-2452

Sep. 25, 2018

Xospata approved in Japan for FLT3 mutation-positive relapsed or refractory AML

Sep. 25, 2018

Beova granted marketing approval in Japan for overactive bladder

Sep. 25, 2018

Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan

Sep. 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...